fda warning compounding semaglutide september 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow Diabetes advocacy group discourages use

Pure Life Peptides GLP-1 Nasal Spray is intended strictly for scientific and investigational use, not for personal or therapeutic application

Endocrinology 2014;155:12801290

Although a popular choice for veterans with Type II diabetes and weight issues, Ozempic carries a risk of considerable gastrointestinal damage, including stomach paralysis

But even if money were not an issue, Hill says, there are a number of other factors that could lead patients to decide not to take GLP-1s long-term (see below)

More recent evidence indicates that sustained GIP receptor agonism in the presence of GLP-1 activation enhances insulin sensitivity and may preferentially reduce visceral adipose tissue

How to Appeal Plan Exclusions or "Not Covered" The challenge: More and more plans are excluding GLP-1s from coverage